Loading clinical trials...

Study of Vitamin A and Carbomer in Comforting the Ocular Surface Irritations of Glaucoma Patients | Clinical Trials | Clareo Health

COMPLETEDNA

Study of Vitamin A and Carbomer in Comforting the Ocular Surface Irritations of Glaucoma Patients

NCT02077231•Xiaodong Zhou

View on ClinicalTrials.gov

Summary

Most of the patients under long application of anti-glaucoma eyedrops endure severe ocular surface irritation, which interrupt their quality of life a lot. Lots of studies aimed to search for new drugs for therapy. The investigators hypothesized that the artificial tears containing vitamin A or carbomer may be a great substitute. Both of the two drugs were in common use and had already been tested in animals.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•\- diagnosed primary open-angle glaucoma or normal tension glaucoma patients with prostaglandin analogs treatment for more than one year.

Exclusion Criteria

•1. any systemic diseases which may cause ocular damage;
•2. previous ocular trauma or surgery;
•3. contact lens wear history in previous 6 months;
•4. application of any artificial tears 3 months ago;
•5. allergic to any of the drugs we used during examination.

Key Dates

Start Date

September 1, 2011

Primary Completion Date

February 1, 2013

Completion Date

September 1, 2013

Last Updated

March 5, 2014

Enrollment

ACTUAL participants

Conditions

Primary Open-angle Glaucoma

Interventions

Vitamin A

DRUG

carbomer eye gel

DRUG

PRESERFLO® MicroShunt Extension Study

NCT04333433

Primary Open-angle Glaucoma

View study

UNKNOWN

Efficacy and Safety Outcomes of Optometrist Performed Selective Laser Trabeculoplasty (SLT)

NCT04036214

Primary Open-Angle Glaucoma, Unspecified EyeOcular Hypertension

View study

COMPLETEDNA

Modified Trabeculectomy With an ESST Versus Conventional SST for Management of Primary Open Angle Glaucoma

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 5, 2014Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Study of Vitamin A and Carbomer in Comforting the Ocular Surface Irritations of Glaucoma Patients

Inclusion Criteria

Exclusion Criteria

PRESERFLO® MicroShunt Extension Study

Efficacy and Safety Outcomes of Optometrist Performed Selective Laser Trabeculoplasty (SLT)

Modified Trabeculectomy With an ESST Versus Conventional SST for Management of Primary Open Angle Glaucoma

Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery

Intraocular Pressure (IOP) Patterns in Fast Versus Slow Visual Field (VF) Progression Patients

Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6